Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Divi's Laboratories reported a consolidated profit after tax (PAT) of ₹583 crore, marginally lower than ₹589 crore in the ...

Reported Consolidated quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,604.00 crore in December 2025 up 12.29% ...

Divi’s Laboratories came under pressure on Monday following a key negative development around a blockbuster cardiac drug. SEBI-registered analyst Prabhat Mittal said Divi’s made an intraday low of ...

On Monday, Nifty 50 closed flat at 24,836.10. The benchmark index however hit an all-time high of 24,999.75. Leading the gains, Divis Laboratories topped the charts with a 2.78% rise in its stock ...

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...

HYDERABAD, Aug 14 (Reuters) - Indian pharmaceutical company Divi's Laboratories (DIVI.NS), opens new tab reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of ...

Reported Standalone quarterly numbers for Divis Laboratories are: Net Sales at Rs 2,578.00 crore in December 2025 up 12.23% ...